Author Bio

Tamar Kahn

Tamar Kahn

Health & Science Correspondent

Tamar Kahn has reported on health and science for Business Day since 2001. She has won awards for news, features and analysis published in Business Day and its sister publication, the Financial Mail, and was the recipient of a Rosalyn Carter fellowship for mental health reporting.

More by Tamar Kahn

SCA allows BHF to continue fight against low-cost medical scheme ruling

Healthcare funders’ body to argue for reopening market to low-cost benefit options after setback in high court

Discovery expands its rewards programme to encourage better sleep

Improving sleep reduced mortality risk by 24%, according to Discovery’s research

Auditor-general raises red flag over state laboratory service’s financial records

A June 2024 cyberattack brought NHLS operations to a virtual standstill, which led to delays in its external audit

Discovery medical scheme defers 2026 contribution increase

Thanks in part to better-than-anticipated returns on its investments, DHMS expects to end the year with a solvency ratio of 31.5%

Big private healthcare profits as watchdog warnings ignored

Open Secrets says market dominance by a few hospital groups and scheme administrators has tightened

Editor’s choice

1

US gold futures top $4,000 as record run powers ahead

2

PODCAST: South Africa’s maize exports to Zimbabwe continue, as the import ban seems to have been eased

3

Police under pressure but not in crisis, Masemola tells MPs

4

WATCH: Equites CEO Andrea Taverna-Turisan on logistics growth and rental trends

5

WATCH: Market Report